Pharmacy Times February 12, 2025
Key Takeaways
- Diversity in clinical trials ensures data reflects diverse populations, crucial for accurate treatment outcomes and addressing health disparities.
- Multi-regional trials enhance diversity but face challenges due to regulatory discrepancies and socioeconomic factors affecting trial participation.
- Biological and genetic diversity, including genetic polymorphisms, significantly impact drug metabolism and trial outcomes.
- International research provides valuable insights into treatment effectiveness across diverse populations, despite challenges in minority representation.
- Regulatory collaboration and innovative trial designs, such as decentralized trials, are essential for improving access and representation in clinical trials.
Diversity in clinical trials remains important to ensure research data for therapies accurately reflects the diverse patient populations who will use them globally.
Diversity in clinical trials is critical to ensure...
Today's Sponsors
Today's Sponsor